{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:45:29Z","timestamp":1793295929722,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008582","name":"McGill University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008582","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.jad.2021.03.022","type":"journal-article","created":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T00:10:31Z","timestamp":1615507831000},"page":"19-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Prescribing Trends of Antidepressants and Psychotropic Coprescription for Youths in UK Primary Care, 2000-2018"],"prefix":"10.1016","volume":"287","author":[{"given":"Thi Xuan Dai","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2096-4742","authenticated-orcid":false,"given":"Lara Fernanda Costa","family":"Fraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Fergusson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Michaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Dell'Aniello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soham","family":"Rej","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Azoulay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4691-9579","authenticated-orcid":false,"given":"Christel","family":"Renoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2021.03.022_bib0001","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.euroneuro.2016.02.001","article-title":"Trends and patterns of antidepressant use in children and adolescents from five western countries, 2005-2012","volume":"26","author":"Bachmann","year":"2016","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.jad.2021.03.022_bib0002","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1001\/jamapediatrics.2017.2896","article-title":"Association of antidepressant medications with incident type 2 diabetes among Medicaid-insured youths","volume":"171","author":"Burcu","year":"2017","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.jad.2021.03.022_bib0003","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jaac.2017.04.004","article-title":"Concomitant use of atypical antipsychotics with other psychotropic medication classes and the risk of type 2 diabetes mellitus","volume":"56","author":"Burcu","year":"2017","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jad.2021.03.022_bib0004","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/pds.3312","article-title":"Off-label antidepressant use in children and adolescents compared with young adults: extent and level of evidence","volume":"21","author":"Czaja","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jad.2021.03.022_bib0005","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1017\/S1461145712001265","article-title":"Polypharmacy with antidepressants in children and adolescents","volume":"17","author":"Diaz-Caneja","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.jad.2021.03.022_bib0006","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3109\/08039488.2011.644809","article-title":"Psychotropic drug and polypharmacy use among adolescents and young adults: findings from the Finnish 1981 Nationwide Birth Cohort Study","volume":"66","author":"Gyllenberg","year":"2012","journal-title":"Nord J Psychiatry"},{"key":"10.1016\/j.jad.2021.03.022_bib0007","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/acps.12633","article-title":"Antidepressant drug use among adolescents during 2004-2013: a population-based register linkage study","volume":"134","author":"Hartz","year":"2016","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.jad.2021.03.022_bib0008","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/ije\/dyv098","article-title":"Data Resource Profile: Clinical Practice Research Datalink (CPRD)","volume":"44","author":"Herrett","year":"2015","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jad.2021.03.022_bib0009","article-title":"Newer generation antidepressants for depressive disorders in children and adolescents","volume":"11","author":"Hetrick","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jad.2021.03.022_bib0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003215","article-title":"Incidence and prevalence of primary care antidepressant prescribing in children and young people in England, 1998-2017: A population-based cohort study","volume":"17","author":"Jack","year":"2020","journal-title":"PLoS Med"},{"key":"10.1016\/j.jad.2021.03.022_bib0011","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1017\/S0033291716002099","article-title":"Recent trends in primary-care antidepressant prescribing to children and young people: an e-cohort study","volume":"46","author":"John","year":"2016","journal-title":"Psychol Med"},{"key":"10.1016\/j.jad.2021.03.022_bib0012","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1001\/archpedi.161.7.690","article-title":"Effect of regulatory warnings on antidepressant prescribing for children and adolescents","volume":"161","author":"Kurian","year":"2007","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.jad.2021.03.022_bib0013","doi-asserted-by":"crossref","DOI":"10.1007\/s00787-018-01269-2","article-title":"Antidepressant prescription patterns and CNS polypharmacy with antidepressants among children, adolescents, and young adults: a population-based study in Sweden","author":"Lagerberg","year":"2019","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"10.1016\/j.jad.2021.03.022_bib0015","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1136\/adc.2004.064956","article-title":"A drug utilisation study of antidepressants in children and adolescents using the General Practice Research Database","volume":"89","author":"Murray","year":"2004","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jad.2021.03.022_bib0020","unstructured":"National Institute for Health and Care Excellence, 2020. Bipolar disorder: assessment and management: https:\/\/www.nice.org.uk\/guidance\/cg185 (accessed 10 December, 2020)."},{"key":"10.1016\/j.jad.2021.03.022_bib0016","unstructured":"National Health Service, Medicines A to Z - Zopiclone, 2019: https:\/\/www.nhs.uk\/medicines\/zopiclone\/ (accessed 10 December 2020)."},{"key":"10.1016\/j.jad.2021.03.022_bib0017","unstructured":"National Institute for Health and Care Excellence, 2005. Obsessive-compulsive disorder and body dysmorphic disorder: treatment: https:\/\/www.nice.org.uk\/guidance\/cg31 (accessed 10 December 2020)."},{"key":"10.1016\/j.jad.2021.03.022_bib0018","unstructured":"National Institute for Health and Care Excellence, 2013. Social anxiety disorder: recognition, assessment and treatment: https:\/\/www.nice.org.uk\/guidance\/cg159 (accessed 10 December 2020)."},{"key":"10.1016\/j.jad.2021.03.022_bib0019","unstructured":"National Institute for Health and Care Excellence, 2019. Depression in children and young people: identification and management: https:\/\/www.nice.org.uk\/guidance\/ng134 (accessed 10 December 2020)."},{"key":"10.1016\/j.jad.2021.03.022_bib0021","article-title":"Antidepressants plus benzodiazepines for adults with major depression","volume":"6","author":"Ogawa","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jad.2021.03.022_bib0022","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00787-015-0726-0","article-title":"Psychotropic medicine prescriptions in Italian youths: a multiregional study","volume":"25","author":"Piovani","year":"2016","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"10.1016\/j.jad.2021.03.022_bib0023","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/JCP.0000000000000891","article-title":"Trends and Patterns of Antidepressant Use in French Children and Adolescents From 2009 to 2016: A Population-Based Study in the French Health Insurance Database","volume":"38","author":"Revet","year":"2018","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.jad.2021.03.022_bib0024","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jad.2016.12.047","article-title":"Temporal trends in antidepressant prescribing to children in UK primary care, 2000\u20132015","volume":"210","author":"Sarginson","year":"2017","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.jad.2021.03.022_bib0025","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/pds.4138","article-title":"Outpatient antidepressant drug use in children and adolescents in Germany between 2004 and 2011","volume":"26","author":"Schr\u00f6der","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jad.2021.03.022_bib0026","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-028201","article-title":"What were the impacts of the Committee on Safety of Medicines warning and publication of the NICE guidelines on trends in child and adolescent antidepressant prescribing in primary care? A population based study","volume":"9","author":"Tiffin","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.jad.2021.03.022_bib0027","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.psychres.2010.06.007","article-title":"Patterns of antidepressant use in Quebec children and adolescents: trends and predictors","volume":"179","author":"Tournier","year":"2010","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.jad.2021.03.022_bib0028","doi-asserted-by":"crossref","first-page":"e33181","DOI":"10.1371\/journal.pone.0033181","article-title":"Trends in depression and antidepressant prescribing in children and adolescents: a cohort study in The Health Improvement Network (THIN)","volume":"7","author":"Wijlaars","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jad.2021.03.022_bib0029","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1089\/cap.2009.0003","article-title":"Psychotropic drug use among Icelandic children: a nationwide population-based study","volume":"19","author":"Zo\u00ebga","year":"2009","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jad.2021.03.022_bib0014","unstructured":"Medicines and Healthcare Products Regulatory Authority, 2003. Selective Serotonin Reuptake Inhibitors (SSRIs): overview of regulatory status and CSM advice relating to major depressive disorder (MDD) in children and adolescents including a summary of available safety and efficacy data: https:\/\/webarchive.nationalarchives.gov.uk\/20141206082100\/http:\/\/www.mhra.gov.uk\/Safetyinformation\/Safetywarningsalertsandrecalls\/Safetywarningsandmessagesformedicines\/CON019494 (accessed 10 December 2020)."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032721002470?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032721002470?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T01:55:36Z","timestamp":1759024536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032721002470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":29,"alternative-id":["S0165032721002470"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2021.03.022","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prescribing Trends of Antidepressants and Psychotropic Coprescription for Youths in UK Primary Care, 2000-2018","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2021.03.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}